Resveratrol Inhibits Arecoline-induced Fibrotic Properties of Buccal Mucosal Fibroblasts Via MiR-200a Activation

Overview

Journal J Dent Sci

Specialty Dentistry

Date 2024 Apr 15

PMID 38618058

Authors

Hui-Wen Yang

Dennis Chun-Yu Ho

Heng-Yi Liao

Yi-Wen Liao

Chih-Yuan Fang

Min Yee Ng

Cheng-Chia Yu

Fu-Chen Lin

Affiliations

Soon will be listed here.

Abstract

Background/purpose: Oral submucous fibrosis (OSF) is a precancerous lesion in the oral cavity, commonly results from the Areca nut chewing habit. Arecoline, the main component of Areca nut, is known to stimulate the activation of myofibroblasts, which can lead to abnormal collagen I deposition. Meanwhile, Resveratrol is a non-flavonoid phenolic substance that can be naturally obtained from various berries and foods. Given that resveratrol has significant anti-fibrosis traits in other organs, but little is known about its effect on OSF, this study aimed to investigate the therapeutic impact of resveratrol on OSF and its underlying mechanism.

Materials And Methods: The cytotoxicity of resveratrol was tested using normal buccal mucosal fibroblasts (BMFs). Myofibroblast phenotypes such as collagen contractile, enhanced migration, and wound healing capacities in dose-dependently resveratrol-treated fBMFs were examined.

Results: Current results showed that arecoline induced cell migration and contractile activity in BMFs as well as upregulated the expressions of α-SMA, type I collagen, and ZEB1 markers. Resveratrol intervention, on the other hand, was shown to inhibit arecoline-induced myofibroblast activation and reduce myofibroblast hallmarks and EMT markers. Additionally, resveratrol was also demonstrated to restore the downregulated miR-200a in the arecoline-stimulated cells.

Conclusion: In a nutshell, these findings implicate that resveratrol may have an inhibitory influence on arecoline-induced fibrosis via the regulation of miR-200a. Hence, resveratrol may be used as a therapeutic strategy for OSF intervention.

Citing Articles

Effects of postbiotics on fibrotic response in arecoline-induced oral fibrogenesis.

Yang P, Chen C, Tsai Y, Liao Y, Ng M, Huang C J Dent Sci. 2024; 19(4):2100-2105.

PMID: 39347080 PMC: 11437315. DOI: 10.1016/j.jds.2024.04.009.

Targeting MetaLnc9/miR-143/FSCN1 axis inhibits oxidative stress and myofibroblast transdifferentiation in oral submucous fibrosis.

Lu M, Hsieh P, Chao S, Fang C, Ohiro Y, Liao Y J Dent Sci. 2024; 19(3):1416-1425.

PMID: 39035266 PMC: 11259661. DOI: 10.1016/j.jds.2024.04.008.

References

Xia Y, Xiao H, Liu K, Zhang H, Tsang S . Resveratrol Ameliorates the Severity of Fibrogenesis in Mice with Experimental Chronic Pancreatitis. Mol Nutr Food Res. 2017; 62(16):e1700561. DOI: 10.1002/mnfr.201700561. View

Hinz B, Celetta G, Tomasek J, Gabbiani G, Chaponnier C . Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell. 2001; 12(9):2730-41. PMC: 59708. DOI: 10.1091/mbc.12.9.2730. View

Warnakulasuriya S . Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2008; 45(4-5):309-16. DOI: 10.1016/j.oraloncology.2008.06.002. View

Lee Y, Hsieh P, Chao S, Liao Y, Liu C, Yu C . α-Mangostin Inhibits the Activation of Myofibroblasts via Downregulation of Linc-ROR-Mediated TGFB1/Smad Signaling. Nutrients. 2023; 15(6). PMC: 10051815. DOI: 10.3390/nu15061321. View

Wei X, Bao Y, Zhan X, Zhang L, Hao G, Zhou J . MiR-200a ameliorates peritoneal fibrosis and functional deterioration in a rat model of peritoneal dialysis. Int Urol Nephrol. 2019; 51(5):889-896. PMC: 6499761. DOI: 10.1007/s11255-019-02122-4. View

Wadhwan V, Venkatesh A, Reddy V, Malik S . The role of myofibroblasts in the progression of oral submucous fibrosis: A systematic review. J Oral Maxillofac Pathol. 2019; 23(2):257-266. PMC: 6714277. DOI: 10.4103/jomfp.JOMFP_238_18. View

Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K . miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS One. 2013; 8(5):e62757. PMC: 3653886. DOI: 10.1371/journal.pone.0062757. View

Sousa A, Liu T, Guevara O, Stevens J, Fanburg B, Gaestel M . Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2. J Cell Biochem. 2006; 100(6):1581-92. PMC: 2586991. DOI: 10.1002/jcb.21154. View

Jiang X, Ai W, Wan L, Zhang Y, Wu J . The roles of microRNA families in hepatic fibrosis. Cell Biosci. 2017; 7:34. PMC: 5496266. DOI: 10.1186/s13578-017-0161-7. View

10.

Ray J, Ranganathan K, Chattopadhyay A . Malignant transformation of oral submucous fibrosis: overview of histopathological aspects. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122(2):200-9. DOI: 10.1016/j.oooo.2015.11.024. View

11.

Tai Y, Woods E, Dally J, Kong D, Steadman R, Moseley R . Myofibroblasts: Function, Formation, and Scope of Molecular Therapies for Skin Fibrosis. Biomolecules. 2021; 11(8). PMC: 8391320. DOI: 10.3390/biom11081095. View

12.

Merchant A, Husain S, Hosain M, Fikree F, Pitiphat W, Siddiqui A . Paan without tobacco: an independent risk factor for oral cancer. Int J Cancer. 2000; 86(1):128-31. DOI: 10.1002/(sici)1097-0215(20000401)86:1<128::aid-ijc20>3.0.co;2-m. View

13.

Prabhu R, Prabhu V, Chatra L, Shenai P, Suvarna N, Dandekeri S . Areca nut and its role in oral submucous fibrosis. J Clin Exp Dent. 2015; 6(5):e569-75. PMC: 4312688. DOI: 10.4317/jced.51318. View

14.

Liao Y, Tsai L, Lee Y, Hsieh P, Yu C, Lu M . miR-21 promotes the fibrotic properties in oral mucosa through targeting PDCD4. J Dent Sci. 2022; 17(2):677-682. PMC: 9201543. DOI: 10.1016/j.jds.2021.09.004. View

15.

Chang Y, Tsai C, Lai Y, Yu C, Chi W, Li J . Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1. J Cell Mol Med. 2014; 18(4):698-708. PMC: 4000120. DOI: 10.1111/jcmm.12219. View

16.

Chen P, Ho D, Liao Y, Hsieh P, Lu K, Tsai L . Honokiol inhibits arecoline-induced oral fibrogenesis through transforming growth factor-β/Smad2/3 signaling inhibition. J Formos Med Assoc. 2021; 120(11):1988-1993. DOI: 10.1016/j.jfma.2021.04.012. View

17.

Dexheimer P, Cochella L . MicroRNAs: From Mechanism to Organism. Front Cell Dev Biol. 2020; 8:409. PMC: 7283388. DOI: 10.3389/fcell.2020.00409. View

18.

Chen H, Lin T, Chiang C, Wey S, Lin F, Yang K . Antifibrotic Effect of Polysaccharide-Resveratrol-Impregnated Dual-Layer Carboxymethyl Cellulose-Based Sponge for The Prevention of Epidural Fibrosis after Laminectomy. Polymers (Basel). 2021; 13(13). PMC: 8271895. DOI: 10.3390/polym13132129. View

19.

Inanaga K, Ichiki T, Matsuura H, Miyazaki R, Hashimoto T, Takeda K . Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis. Hypertens Res. 2009; 32(6):466-71. DOI: 10.1038/hr.2009.47. View

20.

Saito S, Kitabatake M, Ouji-Sageshima N, Ogawa T, Oda A, Nishimura T . Angiopoietin-like 4 Is a Critical Regulator of Fibroblasts during Pulmonary Fibrosis Development. Am J Respir Cell Mol Biol. 2023; 69(3):328-339. DOI: 10.1165/rcmb.2022-0304OC. View